Cargando…
Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs
Given the relatively poor understanding of the expression and functional effects of the N6-methyladenosine (m6A) RNA methylation on colorectal cancer (CRC), we attempted to measure its prognostic value and clinical significance. We comprehensively screened 37 m6A-related prognostic long non-coding R...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417314/ https://www.ncbi.nlm.nih.gov/pubmed/34490250 http://dx.doi.org/10.3389/fcell.2021.698388 |
_version_ | 1783748353094320128 |
---|---|
author | Zeng, Hanqian Xu, Yiying Xu, Shiwen Jin, Linli Shen, Yanyan Rajan, K. C. Bhandari, Adheesh Xia, Erjie |
author_facet | Zeng, Hanqian Xu, Yiying Xu, Shiwen Jin, Linli Shen, Yanyan Rajan, K. C. Bhandari, Adheesh Xia, Erjie |
author_sort | Zeng, Hanqian |
collection | PubMed |
description | Given the relatively poor understanding of the expression and functional effects of the N6-methyladenosine (m6A) RNA methylation on colorectal cancer (CRC), we attempted to measure its prognostic value and clinical significance. We comprehensively screened 37 m6A-related prognostic long non-coding RNAs (lncRNAs) with significant differences in expression based on 21 acknowledged regulators of m6A modification and data on 473 colorectal cancer tissues and 41 para-cancer tissues obtained from the TCGA database. Accordingly, we classified 473 CRC patients into two clusters by consensus clustering on the basis of significantly different survival outcomes. We also found a potential correlation between m6A-related prognostic lncRNAs and BRAF-KRAS expression, as well as immune cell infiltration. Then, we established a prognostic model by selecting 16 m6A-related prognostic lncRNAs via LASSO Cox analysis and grouped the CRC patients into low- and high-risk groups to calculate risk scores. Then, we performed stratified sampling to validate and confirm our model by categorising the 473 samples into a training group (N = 208) and a testing group (N = 205) in a 1:1 ratio. The survival curve showed a distinct clinical outcome in the low- and high-risk subgroups. We reconfirmed the reliability and independence of the prognostic model through various measures: risk curve, heat map and univariate and multivariate Cox analyses. To ensure that the outcomes were applicable to clinical settings, we performed stratified analyses on different clinical features, such as age, lymph node status and clinical stage. CRC patients with downregulated m6A-related gene expression, lower immune score, distant metastasis, lymph node metastasis or more advanced clinical staging had higher risk scores, indicating less-desirable outcomes. Moreover, we explored the immunology of colorectal cancer cells. The risk score showed positive correlations with eosinophils, M2 macrophages and neutrophils. In summary, our effort revealed the significance of m6A RNA methylation regulators in colorectal cancer, and the prognostic model we constructed may be used as an essential reference for predicting the outcome of CRC patients. |
format | Online Article Text |
id | pubmed-8417314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84173142021-09-05 Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs Zeng, Hanqian Xu, Yiying Xu, Shiwen Jin, Linli Shen, Yanyan Rajan, K. C. Bhandari, Adheesh Xia, Erjie Front Cell Dev Biol Cell and Developmental Biology Given the relatively poor understanding of the expression and functional effects of the N6-methyladenosine (m6A) RNA methylation on colorectal cancer (CRC), we attempted to measure its prognostic value and clinical significance. We comprehensively screened 37 m6A-related prognostic long non-coding RNAs (lncRNAs) with significant differences in expression based on 21 acknowledged regulators of m6A modification and data on 473 colorectal cancer tissues and 41 para-cancer tissues obtained from the TCGA database. Accordingly, we classified 473 CRC patients into two clusters by consensus clustering on the basis of significantly different survival outcomes. We also found a potential correlation between m6A-related prognostic lncRNAs and BRAF-KRAS expression, as well as immune cell infiltration. Then, we established a prognostic model by selecting 16 m6A-related prognostic lncRNAs via LASSO Cox analysis and grouped the CRC patients into low- and high-risk groups to calculate risk scores. Then, we performed stratified sampling to validate and confirm our model by categorising the 473 samples into a training group (N = 208) and a testing group (N = 205) in a 1:1 ratio. The survival curve showed a distinct clinical outcome in the low- and high-risk subgroups. We reconfirmed the reliability and independence of the prognostic model through various measures: risk curve, heat map and univariate and multivariate Cox analyses. To ensure that the outcomes were applicable to clinical settings, we performed stratified analyses on different clinical features, such as age, lymph node status and clinical stage. CRC patients with downregulated m6A-related gene expression, lower immune score, distant metastasis, lymph node metastasis or more advanced clinical staging had higher risk scores, indicating less-desirable outcomes. Moreover, we explored the immunology of colorectal cancer cells. The risk score showed positive correlations with eosinophils, M2 macrophages and neutrophils. In summary, our effort revealed the significance of m6A RNA methylation regulators in colorectal cancer, and the prognostic model we constructed may be used as an essential reference for predicting the outcome of CRC patients. Frontiers Media S.A. 2021-08-19 /pmc/articles/PMC8417314/ /pubmed/34490250 http://dx.doi.org/10.3389/fcell.2021.698388 Text en Copyright © 2021 Zeng, Xu, Xu, Jin, Shen, Rajan, Bhandari and Xia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Zeng, Hanqian Xu, Yiying Xu, Shiwen Jin, Linli Shen, Yanyan Rajan, K. C. Bhandari, Adheesh Xia, Erjie Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs |
title | Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs |
title_full | Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs |
title_fullStr | Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs |
title_full_unstemmed | Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs |
title_short | Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs |
title_sort | construction and analysis of a colorectal cancer prognostic model based on n6-methyladenosine-related lncrnas |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417314/ https://www.ncbi.nlm.nih.gov/pubmed/34490250 http://dx.doi.org/10.3389/fcell.2021.698388 |
work_keys_str_mv | AT zenghanqian constructionandanalysisofacolorectalcancerprognosticmodelbasedonn6methyladenosinerelatedlncrnas AT xuyiying constructionandanalysisofacolorectalcancerprognosticmodelbasedonn6methyladenosinerelatedlncrnas AT xushiwen constructionandanalysisofacolorectalcancerprognosticmodelbasedonn6methyladenosinerelatedlncrnas AT jinlinli constructionandanalysisofacolorectalcancerprognosticmodelbasedonn6methyladenosinerelatedlncrnas AT shenyanyan constructionandanalysisofacolorectalcancerprognosticmodelbasedonn6methyladenosinerelatedlncrnas AT rajankc constructionandanalysisofacolorectalcancerprognosticmodelbasedonn6methyladenosinerelatedlncrnas AT bhandariadheesh constructionandanalysisofacolorectalcancerprognosticmodelbasedonn6methyladenosinerelatedlncrnas AT xiaerjie constructionandanalysisofacolorectalcancerprognosticmodelbasedonn6methyladenosinerelatedlncrnas |